<DOC>
	<DOCNO>NCT02153333</DOCNO>
	<brief_summary>This study aim evaluate serologic response PCV-1 serum sample previously collect initiation vaccination series Human Rotavirus ( HRV ) vaccine study ( 1-2 month post Dose 2 HRV vaccine placebo ) . Additionally , pre-vaccination serum sample infant test positive PCV-1 antibody post-vaccination time point also evaluate .</brief_summary>
	<brief_title>Serologic Response Porcine Circovirus Type 1 ( PCV-1 ) Infants Following Administration Rotarix™</brief_title>
	<detailed_description>Serum sample collect 6 clinical trial previously conduct HRV vaccine ( Rotarix™ ) use study .</detailed_description>
	<mesh_term>Rotavirus Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Not applicable subject actively enrol study , serum sample subject part previously conduct trial use test . However , archive serum sample subject satisfy follow criterion include study : Subjects receive two dos HRV vaccine Placebo include ATP cohort immunogenicity primary study list . Subjects parent Legally Acceptable Representatives ( LARs ) agree child ward blood sample could use research give consent primary study list . Subjects sufficient residual volume serum sample pre postvaccination time point .</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>12 Weeks</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Human rotavirus ( HRV ) vaccine</keyword>
	<keyword>Serologic response</keyword>
	<keyword>Porcine circovirus type 1 ( PCV-1 )</keyword>
	<keyword>Laboratory evaluation</keyword>
</DOC>